Cerebellum’s NuVasive, Inc. NUVA Stock Holding History

Cerebellum’s Portfolio NUVA Stock Details NUVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-5,432	Closed	-$344K	–	532
2019 Q3	$344K	Sell	5,432 -616	-10%	-$38.5K	0.22%	329
2019 Q2	$354K	Buy	+6,048	New	+$357K	0.29%	103

Other funds holding NUVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ACA

Anchor Capital Advisors Boston, Massachusetts $3.51B AUM 16.99% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Cerebellum's NUVA Position: Q4 2019 in Review

Cerebellum sold out of NuVasive, Inc. (NUVA) in Q4 2019, closing a stake of 5,432 shares — an estimated $344K sold.

Cerebellum first reported a position in NUVA in Q2 2019 and held it in 2 quarters. The position peaked at $354K in Q2 2019. 290 funds tracked by Wall St. Rank hold NUVA as of Q4 2019.

Cerebellum reported no remaining NuVasive, Inc. position as of Q4 2019 after selling out during the quarter.
Cerebellum sold 5,432 NuVasive, Inc. shares in Q4 2019, an estimated $344K.
Cerebellum first reported a position in NuVasive, Inc. in Q2 2019 and held it in 2 quarters.
Cerebellum's NuVasive, Inc. position peaked at $354K in Q2 2019.
290 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q4 2019.

Based on Cerebellum's 13F filing for Q4 2019, filed 16 Jan 2020.